Extrait

The study is the extension of the LANTU_C_02761 study (core study comparing insulin glargine versus sitagliptin in insulin-naïve patients treated with metformin and not adequately controlled). All patients with HbA1c ≥ 7% at the end of the core study will have the possibility to enter this extension study if they meet the other inclusion criteria and do not present with any exclusion criteria. The main objective of the trial is to assess the glycemic control (HbA1c <7%) of a 3-month combination therapy with metformin, insulin glargine and sitagliptin in patients not adequately controlled by a previous treatment with metformin plus insulin glargine or metformin plus sitagliptin.

Critère d'inclusion

• Type 2 diabetes treated with metformin and not adequately controlled by a previous treatment with metformin and either insulin glargine or sitagliptin

Liens

• ictrp
• ictrp
• ictrp
• ictrp
• euctr
• euctr
• euctr
• euctr
• euctr
• ictrp